Towards Treatment Patterns Validation in Lung Cancer Patients
Authors:
- 6 October 2021
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-8
Abstract
Lung cancer is the leading cause of cancer death. From the estimation of cases that will be in 2021, more than 230,000 new cases are expected to be of lung cancer patients, with an estimation of more than 131,000 deaths. Improving the survival rates or the patient's quality of life is partially covered by a common element: treatments. Collective knowledge about cancer treatment recommendations is typically included in clinical guidelines, intended to optimize patient care and assist clinicians in lung cancer treatment. These guidelines define a set of treatment paths, where recommendations depend on cancer disease aspects and individual features for a concrete patient. Although oncologists are expected to follow clinical guidelines, the inter and intrapatients' variability of response to the possible treatment combinations, makes it necessary to personalize different treatment-patterns on certain cases. Additionally, clinical guidelines are not frequently updated with new findings or lack a consistent methodology when they are frequently updated. For that reason, the analysis of patterns on both patients treated following the standard of care, or outside it, would allow to validate clinical guidelines and identify potential new treatment recommendations. In this work, we have analysed whether actual treatments prescribed to lung cancer patients follow clinical guidelines or not. Using a machine learning method that provides as output association rules (Apriori), we identify patterns based on cancer stage. These preliminary results show that treatments patterns found mostly match with clinical guidelines recommendations, validating the information included in the consulted guidelines.Keywords
Funding Information
- Instituto de Salud Carlos III (AC19/00034)
This publication has 20 references indexed in Scilit:
- Machine learning in precision medicine: lessons to learnNature Reviews Rheumatology, 2020
- Reconstructing the patient’s natural history from electronic health recordsArtificial Intelligence in Medicine, 2020
- SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)Clinical and Translational Oncology, 2018
- Ablative Therapy for Oligometastatic Non–Small Cell Lung CancerClinical Lung Cancer, 2017
- Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung CancerJAMA Oncology, 2017
- Lung Cancer BiomarkersHematology/Oncology Clinics of North America, 2017
- Lung cancer: current therapies and new targeted treatmentsThe Lancet, 2017
- AJCC Cancer Staging Manual2017
- Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyThe Lancet Oncology, 2016
- Palliative Care in Lung CancerSurgical Clinics of North America, 2011